The FDA's 2023-2025 updates to generic drug approvals prioritize U.S.-made medications to fix supply chain gaps. Learn how the new pilot program affects drug availability, pricing, and manufacturing.
The FDA's 2023-2025 updates to generic drug approvals prioritize U.S.-made medications to fix supply chain gaps. Learn how the new pilot program affects drug availability, pricing, and manufacturing.